Patents by Inventor Dale A. Harcourt

Dale A. Harcourt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline
    Patent number: 7943641
    Abstract: A compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: January 3, 2008
    Date of Patent: May 17, 2011
    Assignee: Allergan, Inc.
    Inventors: Ken Chow, Todd M. Heidelbaugh, Phong X. Nguyen, Dale A. Harcourt
  • 7-((1H-IMIDAZOL-4-YL)METHYL)-5,6,7,8-TETRAHYDROQUINOLINE
    Publication number: 20080103175
    Abstract: A compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: January 3, 2008
    Publication date: May 1, 2008
    Inventors: Ken Chow, Todd Heidelbaugh, Phong Nguyen, Dale Harcourt
  • 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline
    Patent number: 7323477
    Abstract: A compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: February 2, 2006
    Date of Patent: January 29, 2008
    Assignee: Allergan, Inc.
    Inventors: Ken Chow, Todd M. Heidelbaugh, Phong X. Nguyen, Dale A. Harcourt
  • 7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline
    Publication number: 20070179182
    Abstract: A compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: February 2, 2006
    Publication date: August 2, 2007
    Inventors: Ken Chow, Todd Heidelbaugh, Phong Nguyen, Dale Harcourt
  • Imidiazoles having reduced side effects
    Patent number: 6841684
    Abstract: Methods and compounds for the treatment of conditions including pain, particularly chronic pain, glaucoma or elevated intraocular pressure with reduced cardiovascular or sedative side effects. Also included are methods of making and using such compounds.
    Type: Grant
    Filed: March 21, 2001
    Date of Patent: January 11, 2005
    Assignee: Allergan, Inc.
    Inventors: Ken Chow, Daniel W. Gil, James A. Burke, Dale A. Harcourt, Michael E. Garst, Larry A. Wheeler, Stephen A. Munk, Dario G. Gomez, Todd M. Heidelbaugh
  • Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
    Publication number: 20030023098
    Abstract: Methods and compounds for the treatment of conditions including pain, particularly chronic pain, glaucoma or elevated intraocular pressure with reduced cardiovascular or sedative side effects. Also included are methods of making and using such compounds.
    Type: Application
    Filed: March 21, 2001
    Publication date: January 30, 2003
    Applicant: ALLERGAN SALES, INC.
    Inventors: Ken Chow, Daniel W. Gil, James A. Burke, Dale A. Harcourt, Michael E. Garst, Larry A. Wheeler
  • Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B / 2C adrenergic receptors
    Publication number: 20020156076
    Abstract: Compounds having adrenergic activity which are a selective agonists for one or both of the &agr;2B and &agr;2c adrenoceptor receptor subtypes in preference to the &agr;2A adrenoceptor receptor subtype; the active compound being selected from the group consisting of compounds having the formula 1
    Type: Application
    Filed: September 6, 2001
    Publication date: October 24, 2002
    Applicant: Allergan Sales, Inc.
    Inventors: Ken Chow, Daniel W. Gil, James A. Burke, Dale A. Harcourt, Michael E. Garst, Larry A. Wheeler, Stephen A. Munk
  • Methods of treating pain and other conditions
    Patent number: 6329369
    Abstract: Methods of treating glaucoma or elevated pressure and other diseases with reduced side effects by treating a mammal in need thereof an agonist of the alpha 2B or alpha 2B/2C adrenergic receptor(s). Also described are compounds having such selective agonist activity.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: December 11, 2001
    Assignee: Allergan Sales, Inc.
    Inventors: Ken Chow, Daniel W. Gil, James A. Burke, Dale A. Harcourt, Michael E. Garst, Larry A. Wheeler, Stephen A. Munk